Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Irish Journal of Medical Science (1971 -)
Metadata
Title
Risk factors for cardiovascular disease in subclinical hypothyroidism
Publication date
01-02-2018
Published in
Irish Journal of Medical Science (1971 -) / Issue 1/2018
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-017-1617-9

Other articles of this Issue 1/2018

Irish Journal of Medical Science (1971 -) 1/2018 Go to the issue

Review Article

Renal nerve stimulation for treatment of neurocardiogenic syncope: a review from perspective of commercialization potential

Original Article

Economics of Early Warning Scores for identifying clinical deterioration—a systematic review

Original Article

Improved mortality outcomes over time for weekend emergency medical admissions

Letter to the Editor

The significance of regression in thin melanoma of the skin

Brief Report

Auditing the frequency and the clinical and economic impact of testing for Fabry disease in patients under the age of 70 with a stroke admitted to Saint Vincent’s University Hospital over a 6-month period

Case based reviews

Metastatic gestational choriocarcinoma: a masquerader in obstetrics

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits